DrSkin Med Spa Wins Best Med Spa 2025 in Gilbert - Earns Triple Recognition Across Categories
The Only Practice in Gilbert, Arizona, Honored in All Three Categories - Med Spa, Skin Care and Plastic Surgery - DrSkin Celebrates Statewide Support in Just Over Two Years of Innovation in Aesthetic Medicine
GILBERT, ARIZONA / ACCESS Newswire / May 29, 2025 / DrSkin Plastic Surgery, Regenerative & Medical Spa, Arizona's destination for plastic surgery and integrative aesthetic medicine, is proud to announce it has been voted Best Med Spa 2025 in the annual Best of Gilbert competition hosted by the Gilbert Sun News. In addition to earning the Top Spot in the Med Spa category, DrSkin Med Spa was also Reader Recommended in Best Skin Care and Best Plastic Surgery - making it the only practice recognized across all three categories.
Now, entering its third year, DrSkin Plastic Surgery, Regenerative & Medical Spa has quickly become a leader in the region by combining the best of Eastern and Western medicine. With a team led by award-winning Top 100 Board-Certified Plastic Surgeon Rohit Jaiswal, MD, and Top Naturopathic Medical Doctor Naomi Placella, NMD, the practice delivers a unique, whole-body approach to beauty and wellness - offering over 200 services designed to help patients feel confident from the inside out.
"This is a big moment for us," said Dr. Rohit Jaiswal, Head of Plastic Surgery at DrSkin Med Spa. "To be the only practice that won and placed in all three categories - and to do so just two-and-a-half years into our journey - is a true testament to the passion, innovation, and care our team brings to every single patient."
A Statewide Thank You
DrSkin Med Spa's leadership emphasized that this achievement wouldn't have been possible without the support of its loyal patient community - not just in Gilbert, but across Arizona.
"We're deeply honored to be named Best Med Spa 2025, and to be recognized among Gilbert's top Skin Care and Plastic Surgery providers," said Dr. Jaiswal. "To our incredible community - both here in Gilbert and across Arizona - thank you. Your trust, support, and votes mean the world to us. We truly wouldn't be here without you."
Innovation That Delivers Results
DrSkin's award-winning care is fueled by a commitment to advanced, results-driven treatments. Patients benefit from breakthrough technologies that offer true permanence like:
Avéli® - Long-term cellulite removal
AviClear® - FDA-approved for permanent reduction in mild to severe acne
miraDry® - Permanent sweat and odor reduction
Renuva® - Revolutionary filler alternative
Resiliélle™ - Regenerative therapy using age zero™ mesenchymal stem cell exosomes
These are just a few of the solutions available at DrSkin Plastic Surgery, Regenerative & Medical Spa, where patients can access the most advanced aesthetic medicine in a welcoming, medically supervised setting.
About DrSkin Med Spa
Located in the heart of Gilbert, DrSkin Med Spa offers a comprehensive range of aesthetic, regenerative, and surgical services for patients seeking natural, lasting results. The practice is known for its personalized care, innovative treatments, and commitment to whole-body wellness.
Related Video
SOURCE: DrSkin Plastic Surgery, Regenerative & Medical Spa
Related Images
DrSkin - BEST OF GILBERT FULL PAGE 10X10.pdf
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ('Keros') (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta ('TGF-ß') family of proteins, today announced that Keros' Chair and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in a fireside chat presentation at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 9:20 a.m. Eastern time. A live audio webcast of the fireside chat presentation will be available at and an archived replay will be accessible in the Investors section of the Keros website at for up to 90 days following the conclusion of the event. About Keros Therapeutics, is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the TGF-ß family of proteins. Keros is a leader in understanding the role of the TGF-ß family of proteins, which are master regulators of the growth, repair and maintenance of a number of tissues, including blood, bone, skeletal muscle, adipose and heart tissue. By leveraging this understanding, Keros has discovered and is developing protein therapeutics that have the potential to provide meaningful and potentially disease-modifying benefit to patients. Keros' lead product candidate, KER-065, is being developed for the treatment of neuromuscular diseases, with an initial focus on Duchenne muscular dystrophy. Keros' most advanced product candidate, elritercept (KER-050), is being developed for the treatment of cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndrome and in patients with myelofibrosis. Investor Contact:Justin Frantzjfrantz@ 617-221-6042 Media Contact:Mahmoud Siddig / Adam Pollack / Viveca TressJoele Frank, Wilkinson Brimmer Katcher(212) 355-4449Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners' Spring 2025 Spotlight Series
Click here to register SAN FRANCISCO, CA / / June 6, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will participate in a virtual fireside chat at 9:00 AM Eastern on Tuesday, June 10, 2025, as part of Lytham Partners' spring 2025 Spotlight Series. The discussion will focus on Jaguar's ongoing efforts to further its orphan disease development programs. Participation Instructions for Jaguar Health's Virtual Fireside Chat During Lytham Partners Spring 2025 Spotlight Series When: Tuesday, June 10, 2025 from 9:00 - 10:00 AM Eastern Where: Online (Click Here). The fireside chat will also be available for replay following the event. About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that Jaguar management will participate in a virtual fireside chat June 10, 2025 as part of Lytham Partners' spring 2025 Spotlight Series. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Contact: hello@ SOURCE: Jaguar Health, Inc. View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Newsweek
3 days ago
- Newsweek
Cities Most at Risk for Rise in Heart Attacks as Canadian Wildfires Burn
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Some residents of several major cities in the Midwest could face an increased risk of heart attack and stroke as smoke from Canadian wildfires continues to descend into the United States this week. "Exposure to particulate matter air pollution causes inflammation in the lungs. This can manifest as worsening of respiratory symptoms, particularly in people with asthma or chronic obstructive pulmonary disease," Dr. Scott Budinger, the chief of pulmonary and critical care in the Department of Medicine at Northwestern University, told Newsweek. "[E]ven more importantly, exposure to particulate matter air pollution acutely increases the risk of heart attacks or strokes," he added. Why It Matters The widespread drift of wildfire smoke from Canada into U.S. metropolitan areas carries significant public health implications. Medical research has documented an association between exposure to fine particulate pollution (PM2.5) and acute increases in heart attacks, strokes, and other cardiovascular events. Vulnerable groups, particularly people living with coronary artery disease, histories of heart attacks or strokes, and chronic respiratory illness, are at elevated risk. With urban centers housing millions, the threat is not only environmental but medical, affecting emergency room capacities and potentially increasing mortality rates. Previous wildfire smoke events, such as those seen in 2023, have already demonstrated the potential for widespread air quality degradation and related health emergencies across city populations. What To Know Smoke from Canadian wildfires has degraded air quality across the Upper Midwest for over a week. The smoke has even reached the U.S. Gulf Coast, where it had less of an impact on physical health. At least eight states were under air quality alerts on Thursday morning, with the U.S. Environmental Protection Agency (EPA) AirNow map showing the current Air Quality Index as "unhealthy" in areas such as Chicago, Illinois, and Lansing and Grand Rapids, Michigan. This AQI is unhealthy for everyone to breathe. A map from the U.S. EPA's AirNow shows cities with unhealthy air quality as of Thursday morning at 11 a.m. Eastern time. A map from the U.S. EPA's AirNow shows cities with unhealthy air quality as of Thursday morning at 11 a.m. Eastern time. AirNow The less severe but still impactful Unhealthy for Sensitive Groups AQI was much more widespread, stretching across parts of Wisconsin, Illinois, Michigan, Indiana, Ohio, and into the Northeast, including Maine and New York. Wildfire smoke contains high concentrations of PM2.5—fine particulate matter that can enter the lungs and bloodstream. Exposure is linked to worsening symptoms in those with asthma or chronic obstructive pulmonary disease (COPD), but acute cardiovascular risks, including heart attacks and strokes, may be even more pronounced. City populations face greater danger when air pollution is trapped near the surface during stagnant weather conditions. In some instances, people were asked to monitor themselves for symptoms such as coughing during the poor air quality event. If coughs persist for more than seven days or are accompanied by shortness of breath, people should visit their doctor or seek more urgent care if necessary. People are urged to remain indoors and keep their windows closed to prevent exposure. What People Are Saying Dr. Scott Budinger, the chief of pulmonary and critical care in the Department of Medicine at Northwestern University, told Newsweek: "People who have known blockages in their arteries or a history of heart attacks or strokes and people with chronic lung diseases like asthma and COPD should avoid exposure. They should also be vigilant about taking all of the prescribed medications for their disease." Budinger added: "You can reduce the risk of exposure by staying indoors with the windows closed. Indoor levels of particulate matter air pollution are typically much lower than those outside in a heated or air conditioned home or business—as much as 10 times less. For example, it might be better to take a walk in a health club or mall rather than outside if the particulate levels are high." An air quality alert issued in Michigan: "It is recommended that, when possible, you avoid strenuous outdoor activities, especially those with heart disease and respiratory diseases like asthma. Monitor for symptoms such as wheezing, coughing, chest tightness, dizziness, or burning in nose, throat, and eyes. Reduce or eliminate activities that contribute to air pollution, such as outdoor burning, and use of residential wood burning devices." What Happens Next Air quality alerts remained in effect in many cities in the Upper Midwest through the end of the week, with meteorologists forecasting that wildfire smoke could persist for several more days. Public health officials continue to advise at-risk populations in major cities to closely monitor advisories, limit outdoor activities during high-pollution periods, and use indoor air filtration.
